DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages


Tinea incognita

Author: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. 2003. Updated by Dr Jannet Gomez, November 2017.

Tinea incognita — codes and concepts

What is tinea incognita?

Tinea incognita is the name given to a fungal skin infection when the clinical appearance has been altered by inappropriate treatment, usually a topical steroid cream. The result is that the original infection slowly extends.

Often the patient and/or their doctor believe they have a dermatitis, hence the use of a topical steroid cream. The steroid cream dampens down inflammation so the condition feels less irritable. But when the cream is stopped for a few days the itch gets worse, so the steroid cream is promptly used again. The more steroid applied, the more extensive the fungal infection becomes and the less recognisable.

Tinea incognita is often incorrectly spelled as tinea incognito. It is also known as steroid-modified tinea. 

Tinea incognita

What causes tinea incognita?

Tinea incognita is due to dermatophyte fungal infection (tinea), most often when it affecting the trunk and/or limbs (tinea corporis). Trichophyton rubrum is the most common organism to cause tinea corporis and tinea incognita in New Zealand. 

Anti-inflammatory creams that can induce tinea incognita include:

Tinea incognita can also be caused by systemic steroids.

Underlying diseases may predispose individuals to infection, especially:

Factors such as sweating, abrasion, and maceration also contribute to the development of infection.

What are the clinical features of tinea incognita?

DermNet's page on tinea corporis describes its usual clinical features. Compared with an untreated tinea corporis, tinea incognita:

  • Has a less raised margin,
  • Is less scaly,
  • More pustular,
  • More extensive,
  • And more irritable.

There may also be secondary changes caused by long term use of a topical steroid such as:

  • Atrophy (thin skin, stretch marks (striae) in the skin folds).
  • Purpura (bruising) and telangiectasia (broken blood vessels).

How is tinea incognita diagnosed?

The diagnosis of tinea is most easily made by taking skin scrapings for microscopy and culture a few days after stopping all creams.

  • If there is little surface scale, the laboratory may report the specimen to be inadequate or negative.
  • After stopping a steroid cream, tinea incognita becomes very inflamed and more fungal elements may be seen on microscopy than usual. 
  • The responsible organism generally grows promptly in culture.

If a skin biopsy is performed, the pathology of tinea incognita reveals the organisms

What is the treatment of tinea incognita?

Tinea is usually treated with topical antifungals (such as miconazole, ketoconazole, econazole), but if the treatment is unsuccessful, oral antifungal medicines may be considered, including terbinafine and itraconazole.

How can tinea incognita be avoided?

Tinea incognita can be avoided if:

  • Patients do not use topical steroids to treat undiagnosed skin conditions 
  • Medical practitioners consider the diagnosis of dermatophyte infection in any scaly or pustular rash that has a prominent and irregular border, and is unilateral or asymmetrical in distribution
  • Mycology is performed when in doubt about the diagnosis of a scaly or pustular rash.



  • Siddaiah N, Erickson Q, Miller G, Elston DM. Tacrolimus-induced tinea incognito. Cutis. 2004 Apr;73(4):237-8. PubMed PMID: 15134322. PubMed.
  • Navarrete‐Dechent C, et al. Rapid diagnosis of tinea incognito using handheld reflectance confocal microscopy: a paradigm shift in dermatology? Mycoses 58.6 (2015): 383-386.
  • Solomon B A, Glass AT, Rabbin PA. Tinea incognito and over-the-counter potent topical steroids. Cutis 58.4 (1996): 295-296.
  • Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016 Mar-Apr;7(2):77-86. doi: 10.4103/2229-5178.178099. Review. PubMed PMID: 27057486; PubMed Central PMCID: PMC4804599

On DermNet NZ

Books about the skin

See the DermNet NZ bookstore.


Related information

Sign up to the newsletter